{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:02:41Z","timestamp":1789095761916,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007301","name":"Kunming University of Science and Technology","doi-asserted-by":"publisher","award":["202202AG050008"],"award-info":[{"award-number":["202202AG050008"]}],"id":[{"id":"10.13039\/501100007301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005273","name":"Natural Science Foundation of Yunnan Province","doi-asserted-by":"publisher","award":["202401CF070152"],"award-info":[{"award-number":["202401CF070152"]}],"id":[{"id":"10.13039\/501100005273","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32160157"],"award-info":[{"award-number":["32160157"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.phymed.2026.158011","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:11:23Z","timestamp":1771891883000},"page":"158011","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Targeting GRB2 with Polyphyllin H overcomes PIKFYVE inhibitor resistance in bladder cancer by blocking Akt\u2013SREBP1\u2013SCD1 pathway"],"prefix":"10.1016","volume":"154","author":[{"given":"Yu-Song","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Kai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu-Shuang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Xuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei-Xue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Rui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2026.158011_bib0001","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.euf.2019.10.017","article-title":"Neoadjuvant therapies for bladder cancer in cisplatin-ineligible patients: what options do we have?","volume":"6","author":"Basu","year":"2020","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.phymed.2026.158011_bib0002","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.phymed.2026.158011_bib0003","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.hoc.2014.10.006","article-title":"First-line treatment of metastatic disease: cisplatin-ineligible patients","volume":"29","author":"Cathomas","year":"2015","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.phymed.2026.158011_bib0004","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1080\/14656566.2023.2254697","article-title":"Pharmacotherapy developments in autophagy inhibitors for bladder cancer","volume":"24","author":"Chaaya","year":"2023","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.phymed.2026.158011_bib0006","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41586-025-08917-z","article-title":"Targeting PIKfyve-driven lipid metabolism in pancreatic cancer","volume":"642","author":"Cheng","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.phymed.2026.158011_bib0007","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1158\/0008-5472.CAN-24-1757","article-title":"Concurrent inhibition of the RAS-MAPK pathway and PIKfyve is a therapeutic strategy for pancreatic cancer","volume":"85","author":"DeLiberty","year":"2025","journal-title":"Cancer Res"},{"key":"10.1016\/j.phymed.2026.158011_bib0008","doi-asserted-by":"crossref","first-page":"ra45","DOI":"10.1126\/scisignal.2004015","article-title":"AKT facilitates EGFR trafficking and degradation by phosphorylating and activating PIKfyve","volume":"6","author":"Er","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.phymed.2026.158011_bib0009","first-page":"47","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J. Natl. Cancer Cent."},{"key":"10.1016\/j.phymed.2026.158011_bib0010","first-page":"4119","article-title":"Phase 1 clinical safety, pharmacokinetics (PK), and activity of apilimod dimesylate (LAM-002A), a first-in-class inhibitor of phosphatidylinositol-3-phosphate 5-kinase (PIKfyve), in patients with relapsed or refractory B-cell malignancies","volume":"130","author":"Harb","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.phymed.2026.158011_bib0011","article-title":"The roles and mechanisms of SREBP1 in cancer development and drug response","volume":"11","author":"He","year":"2024","journal-title":"Genes Dis."},{"key":"10.1016\/j.phymed.2026.158011_bib0012","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","article-title":"The PI3K\u2013AKT network at the interface of oncogenic signalling and cancer metabolism","volume":"20","author":"Hoxhaj","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phymed.2026.158011_bib0013","first-page":"1084","article-title":"The role of Grb2 in cancer and peptides as Grb2 antagonists","volume":"24","author":"Ijaz","year":"2017","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.phymed.2026.158011_bib0014","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12964-018-0295-1","article-title":"Akt1 inhibition promotes breast cancer metastasis through EGFR-mediated \u03b2-catenin nuclear accumulation","volume":"16","author":"Li","year":"2018","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.phymed.2026.158011_bib0015","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.2147\/DDDT.S126464","article-title":"Cisplatin induces protective autophagy through activation of BECN1 in human bladder cancer cells","volume":"11","author":"Lin","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.phymed.2026.158011_bib0016","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cca.2018.01.039","article-title":"Association between obesity and bladder cancer recurrence: a meta-analysis","volume":"480","author":"Lin","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.phymed.2026.158011_bib0017","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3724\/abbs.2024192","article-title":"Anthocyanins and flavonoids derived from Clitoria ternatea L. flower inhibit bladder cancer growth via suppressing fatty acid synthesis mediated by SREBP1 pathway","volume":"57","author":"Liu","year":"2025","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.phymed.2026.158011_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2025.120502","article-title":"Targeting GRB2-Akt-SREBP1 signaling axis by saponins from Paris polyphylla Smith var. yunnanensis (Franch.) Hand.-Mazz to overcome cisplatin resistance in bladder cancer","volume":"354","author":"Liu","year":"2026","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phymed.2026.158011_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2025.120890","article-title":"Paris polyphylla Smith var. yunnanensis-derived saponins potentiate the antitumor activity of GPX4 inhibitors","volume":"357","author":"Liu","year":"2026","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phymed.2026.158011_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216867","article-title":"Autophagy flux in bladder cancer: cell death crosstalk, drug and nanotherapeutics","volume":"591","author":"Liu","year":"2024","journal-title":"Cancer Lett"},{"key":"10.1016\/j.phymed.2026.158011_bib0021","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1073\/pnas.1908158117","article-title":"High-dose ascorbic acid synergizes with anti-PD1 in a lymphoma mouse model","volume":"117","author":"Luchtel","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.phymed.2026.158011_bib0022","article-title":"GRB2: a dynamic adaptor protein orchestrating cellular signaling in health and disease","volume":"39","author":"Malagrin\u00f2","year":"2024","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.phymed.2026.158011_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.juro.2014.07.121","article-title":"The role of EGFR family inhibitors in muscle invasive bladder cancer: a review of clinical data and molecular evidence","volume":"193","author":"Mooso","year":"2015","journal-title":"J. Urol."},{"key":"10.1016\/j.phymed.2026.158011_bib0024","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.3390\/cells13131096","article-title":"Selective termination of autophagy-dependent cancers","volume":"13","author":"Roy","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.phymed.2026.158011_bib0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.canlet.2021.03.030","article-title":"Jolkinolide B targets thioredoxin and glutathione systems to induce ROS-mediated paraptosis and apoptosis in bladder cancer cells","volume":"509","author":"Sang","year":"2021","journal-title":"Cancer Lett"},{"key":"10.1016\/j.phymed.2026.158011_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116194","article-title":"Jolkinolide B synergistically potentiates the antitumor activity of GPX4 inhibitors via inhibiting TrxR1 in cisplatin-resistant bladder cancer cells","volume":"223","author":"Sang","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phymed.2026.158011_bib0027","doi-asserted-by":"crossref","first-page":"re12","DOI":"10.1126\/stke.2003.191.re12","article-title":"SH2 and PTB domains in tyrosine kinase signaling","volume":"2003","author":"Schlessinger","year":"2003","journal-title":"Sci. STKE"},{"key":"10.1016\/j.phymed.2026.158011_bib0028","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1080\/15548627.2019.1586257","article-title":"A family of PIKFYVE inhibitors with therapeutic potential against autophagy-dependent cancer cells disrupt multiple events in lysosome homeostasis","volume":"15","author":"Sharma","year":"2019","journal-title":"Autophagy"},{"key":"10.1016\/j.phymed.2026.158011_bib0029","article-title":"Obesity and risk of bladder cancer: a dose-response meta-analysis of 15 cohort studies","volume":"10","author":"Sun","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.phymed.2026.158011_bib0030","doi-asserted-by":"crossref","first-page":"35","DOI":"10.53388\/TMR20250426002","article-title":"Targeting tumor angiogenesis with traditional Chinese medicine: mechanisms, challenges, and future directions","volume":"11","author":"Wang","year":"2026","journal-title":"Tradit. Med. Res."},{"key":"10.1016\/j.phymed.2026.158011_bib0031","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.985858","article-title":"The relationship between metabolic dysfunction-associated fatty liver disease and the incidence rate of extrahepatic cancer","volume":"14","author":"Wei","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.phymed.2026.158011_bib0032","doi-asserted-by":"crossref","first-page":"18","DOI":"10.53388\/TMR20240618001","article-title":"Rising above: exploring the therapeutic potential of natural product-based compounds in human cancer treatment","volume":"10","author":"Yang","year":"2025","journal-title":"Tradit. Med. Res."},{"key":"10.1016\/j.phymed.2026.158011_bib0033","first-page":"212","article-title":"Cancer statistics in China, 2016","volume":"45","author":"Zheng","year":"2023","journal-title":"Zhonghua Zhong Liu Za Zhi"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326002485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326002485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:02:10Z","timestamp":1776124930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711326002485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":32,"alternative-id":["S0944711326002485"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158011","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting GRB2 with Polyphyllin H overcomes PIKFYVE inhibitor resistance in bladder cancer by blocking Akt\u2013SREBP1\u2013SCD1 pathway","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"158011"}}